Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clinical efficacy of tetrathiomolybdate in advanced kidney cancer

July 11, 2003

FibroGen awarded grant to develop cancer therapies

July 11, 2003

Preliminary findings reveal troponin I suppresses genes associated with angiogenesis

July 11, 2003

Evidence of antitumor efficacy found for PDX in NSCLC

July 11, 2003

IDM exercises option to license cancer epitopes from Epimmune

July 11, 2003

Recent Merck patents cover pyrimidinone KSP inhibitors

July 10, 2003

Trichostatin A potentiates the proapoptotic effects of biomodulators on hepatocellular carcinoma

July 10, 2003

Transient antitumor effects of tipifarnib in hematological malignancies

July 10, 2003

First preclinical data supporting AP-23464 as an alternative to Gleevec

July 9, 2003

PI-88 achieves primary efficacy endpoint in multiple myeloma trial

July 9, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...